Corrigendum to “Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway” [J. Neuroimmunol. 299 (2016) 164–171]

After publication of this article, the authors became aware of a typographical error in Fig. 2A. The immunofluorescence staining image of VAChT and AChE in the sham group in Fig. 2A was inadvertently a duplicate of the BCAS+RAD001 group. The authors apologize for this oversight. All the original data and analyses in the paper have now been thoroughly checked, and the Fig. 2A has been replaced now with the right image based on the original data. We can verify that no data from the analytic results were affected. (Source: Journal of Neuroimmunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2QEEEKS